[go: up one dir, main page]

FR2794371B1 - Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination - Google Patents

Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination

Info

Publication number
FR2794371B1
FR2794371B1 FR9912511A FR9912511A FR2794371B1 FR 2794371 B1 FR2794371 B1 FR 2794371B1 FR 9912511 A FR9912511 A FR 9912511A FR 9912511 A FR9912511 A FR 9912511A FR 2794371 B1 FR2794371 B1 FR 2794371B1
Authority
FR
France
Prior art keywords
obtainment
vaccination
protein fragments
polyepitopic protein
polyepitopic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9912511A
Other languages
English (en)
Other versions
FR2794371A1 (fr
Inventor
Jeannine Choppin
Villada Isabelle Bourgault
Jean Gerard Guillet
Francine Connan
Estelle Ferries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovector Therapeutics SA
Original Assignee
Biovector Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovector Therapeutics SA filed Critical Biovector Therapeutics SA
Priority to FR9912511A priority Critical patent/FR2794371B1/fr
Publication of FR2794371A1 publication Critical patent/FR2794371A1/fr
Application granted granted Critical
Publication of FR2794371B1 publication Critical patent/FR2794371B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9912511A 1999-10-07 1999-10-07 Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination Expired - Fee Related FR2794371B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9912511A FR2794371B1 (fr) 1999-10-07 1999-10-07 Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912511A FR2794371B1 (fr) 1999-10-07 1999-10-07 Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination

Publications (2)

Publication Number Publication Date
FR2794371A1 FR2794371A1 (fr) 2000-12-08
FR2794371B1 true FR2794371B1 (fr) 2004-06-18

Family

ID=9550666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9912511A Expired - Fee Related FR2794371B1 (fr) 1999-10-07 1999-10-07 Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination

Country Status (1)

Country Link
FR (1) FR2794371B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10101890A1 (de) * 2001-01-16 2002-08-01 Deutsches Krebsforsch HPV-spezifische Peptide, die die Bindung von HPV an die Wirtszelle blockieren
FR2839072A1 (fr) * 2002-04-24 2003-10-31 Neovacs Produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, composition immunogene contenant ledit produit d'expression et son procede de preparation
CA2788006C (fr) * 2010-02-16 2021-08-31 Oesterreichische Akademie Der Wissenschaften Anticorps anti-hpv e7

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
FR2641081A1 (fr) * 1988-12-23 1990-06-29 Medgenix Group
IE910909A1 (en) * 1990-03-20 1991-09-25 Behringwerke Ag Seroreactive epitopes of human Papillomavirus (HPV) 16¹proteins
DK0523391T3 (da) * 1991-07-13 2003-06-23 Dade Behring Marburg Gmbh Anvendelse af HPV-16 E6 og E7 genafledte peptider til diagnostisk formål
IL105554A (en) * 1992-05-05 1999-08-17 Univ Leiden Peptides of human papillomavirus for use in preparations elicit a human T cell response
AUPO390396A0 (en) * 1996-11-29 1996-12-19 Csl Limited Novel promiscuous T helper cell epitopes

Also Published As

Publication number Publication date
FR2794371A1 (fr) 2000-12-08

Similar Documents

Publication Publication Date Title
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
ITFI20000154A0 (it) Convogliatore radioelettrico asimmetrico terapeutico.
AU4941101A (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
ATE553129T1 (de) Antikörper gegen humanes il-12
FR2835528B1 (fr) Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
NO20004907D0 (no) Vandig emulsjon og fremstilling derav
FI20012462L (fi) Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
EP1257255A4 (fr) Produit therapeutique, son application et sa formulation
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
EP1168918A4 (fr) Compositions vaccinales et de therapie genique, methodes de production et d'utilisations de celles-ci
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
FR2757860B1 (fr) Composes organoselenies cycliques, leur preparation et leurs utilisations, notamment therapeutiques
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
FR2794371B1 (fr) Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination
FR2806722B1 (fr) Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
FI971872L (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus

Legal Events

Date Code Title Description
TQ Partial transmission of property
RM Correction of a material error
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20140228